Jungle Ventures, the Singapore-based independent venture capital firm, has announced the addition of the HealthXCapital (HXC) team to lead the firm’s healthcare investments in Southeast Asia and India.

The duo said in a statement on Thursday that the ongoing digital transformation in the healthcare industry is driving innovations in advanced diagnostics, personalized medicine, big data, and artificial intelligence (AI), offering significant positive implications for society.

They said this presents a tremendous opportunity for founders and investors to collaborate with innovators ready to shape the future of healthcare for the 2 billion people in Southeast Asia and India.

According to the statement, founded in a joint commitment of driving positive change within healthcare, this move marks a seamless and timely transition in reflection of HXC and Jungle Ventures’ long-standing partnership and shared vision.

“We are very excited to welcome the HXC team to Jungle Ventures as we continue to broaden our diverse portfolio and strengthen our position in the healthcare and build upon our existing investments in the sector,

“Combining the team’s experience and Jungle’s existing network and resources, I am confident that we will create a healthier and more prosperous society, ensuring cutting-edge healthcare solutions are accessible to all,” said Amit Anand, Founding Partner of Jungle Ventures.

It is noted that for nearly eight years, HXC has been at the forefront of the healthcare-dedicated venture fund space.

Their approach, involving a unique convergence of capital, clinical validation, and commercialization through strategic investors from the industry, has established a robust ecosystem for healthcare and healthtech startups in the region.

In the past three years alone, HXC has engaged with over 1200+ founders across diverse healthcare segments, ranging from home care, ambulatory care, insurtech, data sciences to
brain health.

Investing in ten of the most promising ideas and teams in the industry, their portfolio includes renowned names such as RED.Health, Homage, Medfin, and THB, which have showcased incredible growth and resilience even amidst challenging market conditions.

Several of these companies have successfully expanded to multiple geographies and diversified their offerings, capitalizing on the strategic network and support provided by HXC.

Meanwhile, Seemant Jauhari, an experienced leader with 22 years of expertise in Healthcare Investments, Innovation, Business Consulting, and Strategy, will join Jungle Ventures as Partner, Healthcare.

Having led HXC since its inception, he has been instrumental in establishing a smart connected capital platform for healthcare startups in the region.

“It is indeed an exciting time to be a part of Jungle Ventures and lead the healthcare sector-focused investments in India and Southeast Asia,

“I believe that by converging outside-in perspectives derived from investing across sectors and our nuanced understanding of healthcare, we shall be able to bring forth a unique strategic and operational value add to healthcare startups in the region,” said Seemant Jauhari.

Jungle Ventures is a venture capital firm focused on early to growth-stage investments in Southeast Asia and India, with a focus on building long lasting businesses.

The firm partners with the region’s most exciting founders to build high growth, capital-efficient technology businesses, and supports their growth from seed to unicorn to initial public offering (IPO).

Its portfolio includes regional and global category leaders like Kredivo, Moglix, Pomelo, Livspace, Builder.ai, Sociolla and more.

HXC is a Singapore-based early-stage venture fund investing exclusively in healthcare startups targeting the large and underserved emerging Asian markets.

The firm is backed by marquee strategic partners including leading hospitals, financial institutions, impact funds and government; constituting the healthcare ecosystem.

The team at HXC comprises of domain experts with a specialization in investing and assisting healthcare companies commercialize their products and services in the region via a network of partnerships.

Singapore’s B Capital closes inaugural healthcare fund at $500M